CD47 and acute myeloid leukemia: It is widely expressed on hematopoietic and non-hematopoietic cells; however, we previously found that CD47 was more highly expressed on AML LSC than their normal counterparts, and that increased CD47 expression in AML is associated with poor clinical outcomes [6,7,12].